ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $204,750 | -21.1% | 81,900 | 0.0% | 0.00% | – |
| Q4 2022 | $259,623 | +13.9% | 81,900 | +6.9% | 0.00% | – |
| Q3 2022 | $228,000 | +11.8% | 76,600 | +14.5% | 0.00% | – |
| Q2 2022 | $204,000 | -71.1% | 66,900 | +28.2% | 0.00% | – |
| Q1 2022 | $705,000 | -1.3% | 52,200 | -4.7% | 0.00% | – |
| Q4 2021 | $714,000 | +38.9% | 54,800 | 0.0% | 0.00% | – |
| Q3 2021 | $514,000 | -8.4% | 54,800 | 0.0% | 0.00% | – |
| Q2 2021 | $561,000 | – | 54,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |